InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Engages Global CRO to Support NDA Submission for Approval of Tonmya(TM) for Fibromyalgia Management
Tonix Pharmaceuticals Holding (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, has engaged Rho, Inc., a global contract research organization (“CRO”). Under the terms of the engagement, Rho will support Tonix in preparing its New Drug Application (“NDA”) for planned submission to the U.S. Food and Drug Administration (“FDA”) for the clearance of Tonmya(TM), a patented sublingual tablet formulation…